Robert J. Laffan - Concepedia

Author

Robert J. Laffan

Also Known As

Laffan, Robert Joseph, R J LAFFAN, R J Laffan, R Laffan, R. J. LAFFAN, R. J. Laffan, R. Laffan, R.J. Laffan, Robert J. LAFFAN, Robert J. Laffan

Publications

855

Citations

H-Index

Concepts

All Affiliations

Institute for Medical Research Bristol-Myers Squibb (Sweden)

About

Robert J. Laffan is an author at Institute for Medical Research specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	509
2	Natural Sciences	1	1	210
3	Public Health	1	1	39
4	Social Sciences	1	1	30
5	Biochemistry	1	1	210

Robert J. Laffan

Publications

832

Citations

H-Index

Page 1

	Year	Citations
SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme. Bernard Rubin, Robert J. Laffan, D G Kotler, Journal of Pharmacology and Experimental Therapeutics Molecular PharmacologyMedicinal ChemistryActive InhibitorInhibitory ActivityBiochemistry	1978	210
Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme. Robert J. Laffan, M.E. Goldberg, John P. High, Journal of Pharmacology and Experimental Therapeutics	1978	173
Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression Robert J. Lee, Dale B. Evans, Sherrin H. Baky, European Journal of Pharmacology Direct Myocardial DepressionMolecular PharmacologyMedicinePhysiologyCardiovascular Pharmacology	1975	96
EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL(SQ 14,225), AN ORALLY ACTIVE INHIBITOR OFANGIOTENSIN I-CONVERTING ENZYME, INSPONTANEOUSLY HYPERTENSIVE RATS Michael J. Antonaccio, Bernard Rubin, Zola P. Horovitz, The Japanese Journal of Pharmacology	1979	94
Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats Bernard Rubin, Michael J. Antonaccio, Morton E. Goldberg, European Journal of Pharmacology HypertensionChronic Antihypertensive EffectsMedicineChronic Kidney DiseasePhysiology	1978	62
EMETIC ACTION OF NICOTINE AND LOBELINE Robert J. Laffan, Herbert L. Borison Journal of Pharmacology and Experimental Therapeutics	1957	44
Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals Antonio Bianchi, Dale B. Evans, Malcolm Cobb, European Journal of Pharmacology HypertensionPhysiological ResearchAdrenal GlandNeurophysiologyMedicine	1973	39
Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs Don N. Harris, Christopher L. Heran, Harold Goldenberg, European Journal of Pharmacology Animal PhysiologyHypertensionHeart RateCardiovascular DiseaseMedicine	1978	39
Anti-arrhythmic action of nadolol, a β-adrenergic receptor blocking agent Dale B. Evans, Maria T. Peschka, Robert J. Lee, European Journal of Pharmacology Molecular PharmacologyMedicinePhysiologyβ-Adrenergic ReceptorCardiovascular Pharmacology	1976	33
A technique for prolonged, continuous recording of blood pressure of unrestrained rats Robert J. Laffan, Alan C. Peterson, S. W. HITCH, Cardiovascular Research HypertensionSingle TransducerBiomedical EngineeringBlood PressureSocial Sciences	1972	30

Page 1